Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Safety of Ibuprofen in Patients With COVID-19

(2020) Mohit Sodhi et al.   CHEST

Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

(2020) Durga Prasanna Misra et al.   CLINICAL RHEUMATOLOGY

SARS-CoV-2: a storm is raging

(2020) Savannah F. Pedersen et al.   JOURNAL OF CLINICAL INVESTIGATION

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

(2020) Xiuyuan Ou et al.   Nature Communications

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

(2020) Tao Chen et al.   BMJ-British Medical Journal

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Type 1 interferons as a potential treatment against COVID-19

(2020) Erwan Sallard et al.   ANTIVIRAL RESEARCH

Ibuprofen use and clinical outcomes in COVID-19 patients

(2020) E. Rinott et al.   CLINICAL MICROBIOLOGY AND INFECTION

Does Ibuprofen Worsen COVID-19?

(2020) Nicholas Moore et al.   DRUG SAFETY

Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study

(2020) Firouzé Bani-Sadr et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Longitudinal analyses reveal immunological misfiring in severe COVID-19

(2020) Carolina Lucas et al.   NATURE

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

(2020) Leora R. Feldstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management

(2020) Mina T. Kelleni   PHARMACOLOGICAL RESEARCH

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

(2020) Mayla Gabriela Silva Borba et al.   JAMA Network Open

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19

(2020) Bruno M. Tomazini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

(2020) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

(2020) Liqiang Feng et al.   Nature Communications

Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study

(2020) Lars Christian Lund et al.   PLOS MEDICINE

ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror

(2020) Mina T. Kelleni   INFLAMMOPHARMACOLOGY

A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality

(2020) Lucinda Smart et al.   INFLAMMOPHARMACOLOGY

Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy

(2012) Nicholas I. Paton et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION